REFERENCES
- Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607–14.
- Vance DE. In: Vance DE, editor. Phosphatidyl-choline metabolism. Boca Raton: CRC Press, 1989: 225–39.
- Kaiser E, Chiba P, Zaky K. Phospholipases in biology and medicine. Clin Biochem 1990; 23: 349— 70.
- Gross RW. Myocardial phospholipase A2 and their membrane substrates. Trends Cardivasc Med 1992; 2: 115–21.
- Kroll MH, Schafer Al. Biochemical mechanisms of platelet activation. Blood 1989; 74: 1181–95.
- McHowat J, COff PB. Thrombin-induced release of lysophosphatidylcholine from endothelial cells. J Biol Chem 1993; 268: 15605–10.
- Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA .1984; 81:: 3883–7.
- Glomset JA, Assmann G, Gjone E, Norum KR. Lecithin: cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill Inc., 1995: 1933–55.
- Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of athero-genic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992; 90: 1138–44.
- Kume N, Gimbrone MA Jr. Lysophosphatidyl-choline transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994; 93: 907–11.
- Zembowicz A, Jones SL, Wu KK. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest 1995; 96: 1688–92.
- Zembowicz A, Tang J, Wu KK. Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem 1995; 270: 17006–10.
- Mangin EL Jr, Kugiyama K, Nguy JH, Kerns SA, Henry PD. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res 1993; 72: 161–6.
- Quinn MT, Parthasarathy S, Steinberg D. Lyso-phosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 1987; 85: 2805–9.
- Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 1983; 3: 149–59.
- Saxena U, Witte LD, Goldberg U. Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem 1989; 264: 4349— 55.
- Marinetti GV. Chromatografic separation, identi-fication, and analysis of phosphatides. J Lipid Res 1962; 3: 1–20.
- Dvorak AM, Letourneau L, Login GR, Weller PF, Ackerman SJ. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospho-lipase) to a distinct crystalloid-free granule popu-lation in mature human eosinophils. Blood 1988; 72: 150–8.
- Camps L, Reina M, Llobera M, Vilaró S, Olivecrona T. Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol 1990; 258: C673–81.
- Endresen MJR, Lorentzen B, Henriksen T. Increased lipolytic activity of sera from pre-eclamptic women due to the presence of a lysophospholipase. Scand J Clin Lab Invest 1993; 53: 733–9.